Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001415889-24-008974

Options or other derivatives

  • CHIEF FINANCIAL OFFICER acquired 12,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
KENYON LAWRENCE A CHIEF FINANCIAL OFFICER 2024-03-20 Grant or award · Stock Option (Right to Buy) +12,500 12,500 D
Loading xslF345X05/form4-03222024_050315.xml…